News
Evotenix receives patent for gene synthesis method
The patent further strengthens Evotenix’s IP portfolio and is a key milestone in the company’s strategy to simplify gene synthesis for users. It is also anticipated to enable a new generation of in-lab DNA synthesis platforms.